Patent Assignment
Reel/Frame 071810/0317
Security Interest
Recorded: 2025-07-23
Pages: 8
Assignee
THE BANK OF NOVA SCOTIA
40 KING STREET WEST, SCOTIA PLAZA, TORONTO, M5H 1H1, CANADA
Covered Properties
(3)
Foamable Formulation
Foamable Formulation
Solid Forms of Upadacitinib
Application:
18/737,389 →
Publication:
US 2024/0409547
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 19, 2012
From: BUYUKTIMKIN, SERVET; BUYUKTIMKIN, NADIR; KISAK, EDWARD T.; SINGH, JAGAT
To: NUVO RESEARCH INC.
Reel/Frame 029158/0954 →
Assignment of Assignor's Interest
Jul 24, 2015
From: BUYUKTIMKIN, SERVET; BUYUKTIMKIN, NADIR; KISAK, EDWARD T.; SINGH, JAGAT
To: NUVO RESEARCH INC.
Reel/Frame 036177/0676 →
Assignment of Assignor's Interest
Nov 28, 2016
From: NUVO RESEARCH INC.
To: CRESCITA THERAPEUTICS INC.
Reel/Frame 040434/0653 →
Assignment of Assignor's Interest
Jun 15, 2017
From: CRESCITA THERAPEUTICS INC.
To: NUVO PHARMACEUTICALS INC.
Reel/Frame 042727/0965 →
Assignment of Assignor's Interest
Oct 25, 2017
From: CRESCITA THERAPEUTICS INC.
To: NUVO PHARMACEUTICALS INC.
Reel/Frame 043942/0119 →
Security Interest
Dec 31, 2018
From: NUVO PHARMACEUTICALS INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY; ARALEZ PHARMACEUTICALS CANADA INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
Reel/Frame 047875/0410 →
Release of Security Interest
Mar 14, 2023
From: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
To: NUVO PHARMACEUTICALS INC.; ARALEZ PHARMACEUTICALS CANADA INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY (F/K/A NUVO PHARMACEUTICALS (IRELAND) LIMITED)
Reel/Frame 062974/0236 →
Change of Name
Jun 8, 2023
From: NUVO PHARMACEUTICALS INC.
To: ARALEZ PHARMACEUTICALS CANADA INC.
Reel/Frame 063939/0541 →
Assignment of Assignor's Interest
Sep 30, 2024
From: PRICE, JEFFREY S.; SOUZA, FABIO E. S.; REY, ALLAN W.; KONDAMREDDY, MURALI
To: APOTEX INC.
Reel/Frame 068738/0749 →